Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 337,151
  • Shares Outstanding, K 31,598
  • Annual Sales, $ 14,860 K
  • Annual Income, $ -39,590 K
  • 60-Month Beta 2.29
  • Price/Sales 21.63
  • Price/Cash Flow N/A
  • Price/Book 6.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.05
  • Number of Estimates 1
  • High Estimate 0.05
  • Low Estimate 0.05
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +122.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.58 +21.79%
on 10/16/19
11.39 -8.25%
on 11/08/19
+1.57 (+17.68%)
since 10/11/19
3-Month
6.28 +66.40%
on 08/12/19
11.39 -8.25%
on 11/08/19
+4.15 (+65.87%)
since 08/09/19
52-Week
3.13 +233.87%
on 01/02/19
11.39 -8.25%
on 11/08/19
+5.40 (+106.93%)
since 11/09/18

Most Recent Stories

More News
Pfenex (PFNX) Matches Q3 Earnings Estimates

Pfenex (PFNX) delivered earnings and revenue surprises of 0.00% and 3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PFNX : 10.45 (-2.06%)
Pfenex to Present at the Jefferies 2019 London Healthcare Conference

Pfenex Inc. (NYSE American: PFNX) today announced that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Jefferies 2019 London Healthcare Conference on Wednesday, November...

PFNX : 10.45 (-2.06%)
Pfenex (PFNX) Reports Next Week: Wall Street Expects Earnings Growth

Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PFNX : 10.45 (-2.06%)
Pfenex to Announce Third Quarter 2019 Financial Results on November 7th

Pfenex Inc. (NYSE American: PFNX), a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...

PFNX : 10.45 (-2.06%)
Implied Volatility Surging for Pfenex (PFNX) Stock Options

Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.

PFNX : 10.45 (-2.06%)
Shares of Pfenex Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PFNX, VCYT , KPTI , GBT , REGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 15.28 (+3.80%)
VCYT : 23.48 (-0.47%)
PFNX : 10.45 (-2.06%)
Watch for Pfenex Inc to Potentially Pullback After Gaining 3.53% Yesterday

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $8.47 to a high of $9.03. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $8.86 on...

PFNX : 10.45 (-2.06%)
Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....

MHMNF : 54.5000 (unch)
SOLY : 10.17 (-3.97%)
AKCA : 19.37 (+0.31%)
LVGO : 25.88 (+2.50%)
PFNX : 10.45 (-2.06%)
GILD : 64.64 (-1.13%)
Pfenex Inc has the Best Relative Performance in the Biotechnology Industry (PFNX, HRTX , NTRA , FLXN , ARWR)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

HRTX : 20.59 (-4.10%)
NTRA : 37.34 (+1.25%)
PFNX : 10.45 (-2.06%)
ARWR : 42.94 (+2.00%)
2.1% Return Seen to Date on SmarTrend Pfenex Inc Call (PFNX)

SmarTrend identified a Downtrend for Pfenex Inc (AMEX:PFNX) on September 23rd, 2019 at $8.72. In approximately 2 weeks, Pfenex Inc has returned 2.13% as of today's recent price of $8.53.

PFNX : 10.45 (-2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade PFNX with:

Business Summary

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform...

See More

Key Turning Points

2nd Resistance Point 10.94
1st Resistance Point 10.69
Last Price 10.45
1st Support Level 10.11
2nd Support Level 9.78

See More

52-Week High 11.39
Last Price 10.45
Fibonacci 61.8% 8.23
Fibonacci 50% 7.26
Fibonacci 38.2% 6.29
52-Week Low 3.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar